Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

You may be eligible if

• Patients with unequivocal diagnosis of multiple sclerosis and have evidence of C. pneumoniae infection in the cerebral spinal fluid